Abstract
We report the first successful carotid stent implant in a patient with heparin-induced thrombocytopenia and thrombosis syndrome who presented with recurrent neurologic deficits secondary to severe carotid stenosis. Argatroban anticoagulation was used for the carotid stent deployment. We also present laboratory data that document effective procedural anticoagulation.
MeSH terms
-
Aged
-
Anticoagulants / adverse effects*
-
Antithrombins / administration & dosage
-
Antithrombins / therapeutic use*
-
Arginine / analogs & derivatives
-
Carotid Arteries*
-
Carotid Stenosis / complications
-
Carotid Stenosis / therapy*
-
Catheterization
-
Cerebrovascular Disorders / etiology
-
Femoral Artery
-
Follow-Up Studies
-
Heparin / adverse effects*
-
Humans
-
Male
-
Paresis / etiology
-
Pipecolic Acids / administration & dosage
-
Pipecolic Acids / therapeutic use*
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Recurrence
-
Stents*
-
Sulfonamides
-
Syndrome
-
Thrombocytopenia / chemically induced*
-
Thrombosis / chemically induced*
Substances
-
Anticoagulants
-
Antithrombins
-
Pipecolic Acids
-
Platelet Aggregation Inhibitors
-
Sulfonamides
-
Heparin
-
Arginine
-
argatroban